National brain tumour research funding needs to increase to £35 million a year
Weekly pick of brain tumour research news from around the world
A cancer tumour's ability to mutate allows it to escape from chemotherapy however research, that included research into paediatric brain tumours, has found that by creating this resistance tumours had increased their sensitivity to immunotherapy. The team involved are hoping to translate this work into clinical trials for paediatric brain tumours within the next year. The Institute of Cancer Research (ICR) are part of this research and their more detailed overview is here
For children with high risk brain tumours that resist standard therapy, the next step is often enrolling in a clinical trial. Connecting these young patients with the most promising therapies in the world is often a complicated and lengthy process. To address this challenge, an elite, global network of children’s hospitals are teaming up to accelerate access to clinical trials for children with incurable brain cancer
With Proton Beam Therapy about to come on stream in the UK this timely report from the National Cancer Institute in the US asks Is Proton Therapy Safer than Traditional Radiation?
For patients with a brain tumour, the first step in treatment is often surgery to remove as much of the mass as possible. A tumour sample obtained and analysed during surgery can help to precisely diagnose the tumour and define the margins between tumour and healthy brain tissue. However, such intraoperative pathology analysis takes time—the sample must be processed, stained, and analysed by a pathologist while the surgeon and patient wait for the results. Now, a new study shows that a process combining an advanced imaging technology and artificial intelligence (AI) can accurately diagnose brain tumours in fewer than 3 minutes during surgery.
Pet dogs develop gliomas about as often as humans do and they arise in adult dogs at the age of human children in calendar years. A new paper's findings provide important insight into canine gliomas and indicate that the results are likely to be relevant to human gliomas and potential therapies, particularly in children leading to the question “Could man’s best friend improve treatment options for glioma patients?”
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.